Sector
HealthcareOpen
₹3,244.8Prev. Close
₹3,236.25Turnover(Lac.)
₹3,734.09Day's High
₹3,295.95Day's Low
₹3,24052 Week's High
₹3,459.452 Week's Low
₹1,943.7Book Value
₹242.02Face Value
₹10Mkt Cap (₹ Cr.)
27,368.9P/E
65.39EPS
49.5Divi. Yield
0.56Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 83.48 | 83.37 | 83.35 | 83.35 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,816.18 | 1,606.5 | 1,388.77 | 1,133.74 |
Net Worth | 1,899.66 | 1,689.87 | 1,472.12 | 1,217.09 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 1,872.7 | 1,490.55 | 1,273.59 | 1,024.04 |
yoy growth (%) | 25.63 | 17.03 | 24.36 | 16.12 |
Raw materials | -446.31 | -373.9 | -286.86 | -219.31 |
As % of sales | 23.83 | 25.08 | 22.52 | 21.41 |
Employee costs | -320.22 | -257.43 | -232.06 | -175.08 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 459.39 | 374.04 | 302.75 | 255.31 |
Depreciation | -75.31 | -69.77 | -68 | -31.04 |
Tax paid | -115.34 | -93.93 | -79.57 | -87.33 |
Working capital | -358.09 | 332.24 | 134.44 | 87.45 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 25.63 | 17.03 | 24.36 | 16.12 |
Op profit growth | 25.24 | 24.27 | 28.21 | 11.1 |
EBIT growth | 25.47 | 22.51 | 23.92 | 10.42 |
Net profit growth | 22.82 | 25.5 | 32.85 | 10.16 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 2,226.6 | 2,016.9 | 2,087.4 | 1,581.3 | 1,330.4 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,226.6 | 2,016.9 | 2,087.4 | 1,581.3 | 1,330.4 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 69.2 | 41.7 | 52.5 | 51.3 | 55 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,030.25 | 96.49 | 1,01,128.06 | 251.7 | 0.23 | 1,936.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 984.85 | 130.7 | 93,514.24 | 154.14 | 0.16 | 621.39 | 79.01 |
Fortis Healthcare Ltd FORTIS | 590.5 | 338.86 | 44,769.02 | 26.83 | 0.17 | 333.4 | 120.36 |
Syngene International Ltd SYNGENE | 902.1 | 79.82 | 35,922.4 | 73.9 | 0.14 | 726.5 | 104.14 |
Global Health Ltd MEDANTA | 1,098 | 80.66 | 29,913.49 | 96.28 | 0 | 611.45 | 106.08 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
Arvind Lal
Whole-time Director
Vandana Lal
Non Executive Director
Archana Lal Erdmann
Managing Director
Om Prakash Manchanda
Non Executive Director
Rahul Sharma
Independent Director
Somya Satsangi
Independent Director
Rohit Bhasin
Independent Director
Arun Duggal
Independent Director
Gurinder Singh Kalra
Independent Director
RAJIT MEHTA
Company Sec. & Compli. Officer
Vinay Gujral
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Dr Lal Pathlabs Ltd
Summary
Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres. Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.Presently, the Company is engaged the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company has built a national, hub and spoke network that includes its National Reference Laboratory in New Delhi, Regional Reference Lab in Kolkata and 371 other clinical laboratories, 5,102 patient service centers and 10,938 pickup points as of 31 March 2023. Its customers include individual patients, hospitals and other healthcare providers and corporate customers. Apart from these, the catalogue of services includes 481 test panels, 2763 pathology tests and 1947 radiology and cardiology tests.Late Dr. Major S.K. Lal, commenced the business of providing pathology services and maintaining a blood bank in the year 1949 through sole propriet
Read More
The Dr Lal Pathlabs Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹3274.8 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Lal Pathlabs Ltd is ₹27368.90 Cr. as of 19 Sep ‘24
The PE and PB ratios of Dr Lal Pathlabs Ltd is 65.39 and 14.24 as of 19 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Dr Lal Pathlabs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dr Lal Pathlabs Ltd is ₹1943.7 and ₹3459.4 as of 19 Sep ‘24
Dr Lal Pathlabs Ltd's CAGR for 5 Years at 21.26%, 3 Years at -6.39%, 1 Year at 37.04%, 6 Month at 60.89%, 3 Month at 18.81% and 1 Month at -2.25%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice